GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Summit Therapeutics Inc (MEX:SMMT) » Definitions » Other Assets for Insurance Companies

Summit Therapeutics (MEX:SMMT) Other Assets for Insurance Companies


View and export this data going back to 2024. Start your Free Trial

What is Summit Therapeutics Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


Summit Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
601 Brickell Key Drive, Suite 1000, Miami, FL, USA, 33131
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.